4.8 Article

Carbon nanotube-protein carriers enhance size-dependent self-adjuvant antibody response to haptens

Journal

JOURNAL OF CONTROLLED RELEASE
Volume 170, Issue 2, Pages 242-251

Publisher

ELSEVIER
DOI: 10.1016/j.jconrel.2013.05.019

Keywords

Antigen delivery; Antibodies; Azoxystrobin; Biomaterials; Carbon nanotubes; Immunization

Funding

  1. Ministerio de Educacion y Ciencia [AGL2009-12940-C02-01/02/ALI]
  2. FEDER
  3. Ministerio de Ciencia e Innovacion
  4. European Social Fund

Ask authors/readers for more resources

Carbon nanotubes (CNTs) are nanomaterials with interesting emerging applications. Their properties make CNTs excellent candidates for use as new nanovehicles in drug delivery, immunization and diagnostics. In the current study, we assessed the immune-response-amplifying properties of CNTs to haptens by using azoxystrobin, the first developed strobilurin fungicide, as a model analyte. An azoxystrobin derivative bearing a carboxylated spacer arm (hapten AZc6) was covalently coupled to bovine serum albumin (BSA), and the resulting BSA-AZc6 conjugate was covalently linked to four functionalized CNTs of different shapes and sizes, varying in diameter and length. These four types of CNT-based constructs were obtained using efficient, fast, and easy functionalization procedures based on microwave-assisted chemistry. New Zealand rabbits and BALB/c mice were immunized with BSA-AZc6 alone and with the four CNT-BSA-AZc6 constructs, both with and without Freund's adjuvant. The IgG-type antibody responses were assessed in terms of the titer and affinity, paying special attention to the relationship between the immune response and the size and shape of the employed CNTs. Immunization with CNT-BSA-AZc6 resulted in enhanced titers and excellent affinities for azoxystrobin. More important, remarkable IgG responses were obtained even in the absence of an adjuvant, thus proving the self-adjuvanting capability of CNTs. Immunogenswere able to produce strong anti-azoxystrobin immune responses in rabbits even when administered at a BSA-AZc6 conjugate dose as low as 0.05 mu g. The short and thick CNT-BSA-AZc6 construct produced the best antibody response under all tested conditions. (C) 2013 Elsevier B. V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available